TRANSPARENCY & GOVERNANCE

SciNarris Editorial Policy

How SciNarris approaches educational content development, accuracy, referencing standards, and objective presentation for medical communication learners.

Our Editorial Purpose

SciNarris is an independent educational platform created to help pharmacy students, life science graduates, aspiring medical writers, and early-career professionals understand the fundamentals of medical writing and healthcare communication.

Our editorial focus is entirely educational. We aim to clarify complex concepts—such as claim substantiation, reference linking, MLR review workflows, and regulatory preclearance principles—using structured explanations, practical examples, and transparent source references.

1. Educational Scope

All content published on SciNarris is designed strictly for educational and training purposes. Our materials focus on teaching the principles of medical communication, including:

  • Fundamentals of medical writing and medical communications.
  • Core concepts of promotional medical writing, claims, and evidence evaluation.
  • Line-referencing standards and citation practices in pharmaceutical communications.
  • Practical workflow concepts behind Medical, Legal, and Regulatory (MLR) review.
  • General principles of regulatory advertising preclearance ecosystems.

2. Accuracy and Clarity

We prioritize clear, plain-language explanations without sacrificing technical or scientific precision. When drafting educational lessons and explainers:

  • We define specialized medical writing terminology clearly upon first use.
  • We distinguish between established regulatory/scientific guidelines and educational commentary.
  • We break down multi-step review workflows into practical, understandable components.
  • We avoid vague or ambiguous statements regarding how evidence supports clinical claims.

3. Use of Scientific & Authoritative Sources

SciNarris relies on recognized primary and public authoritative sources when developing content. Depending on the subject matter, sources may include:

  • Peer-reviewed clinical journals and published clinical trial data.
  • Official regulatory documents and health authority guidelines (e.g., Health Canada, US FDA).
  • Official advertising review codes and guidance documents.
  • Established medical writing professional association resources (e.g., AMWA, EMWA, ISMPP guidelines).

4. Balanced Presentation of Information

In medical communication, responsible writing requires fair balance—presenting risk and safety information alongside efficacy claims. SciNarris applies this same commitment to educational balance:

  • We highlight trial limitations, secondary endpoints, and study design contexts rather than cherry-picking favorable data.
  • We illustrate how fair balance and risk disclosure work in realistic promotional medical writing scenarios.
  • We avoid sensationalized headlines or exaggerated claims about career outcomes or industry practices.

5. Practical Examples & Original Educational Writing

All educational text on SciNarris is originally written specifically for our learning modules. To make learning practical:

  • We construct hypothetical scenario examples and before/after copy revisions to demonstrate key principles.
  • Hypothetical examples use generic or illustrative clinical parameters and do not represent proprietary commercial campaigns.
  • Illustrative visuals created with generative AI tools are labeled accordingly with visual disclosures.

6. What SciNarris Does Not Claim

To maintain complete transparency with our learners and readers, SciNarris explicitly clarifies the following:

  • No Formal Peer Review Claim: Content is developed for educational instruction and is not subjected to journal peer review.
  • No Clinical Validation Claim: SciNarris does not clinically validate third-party medical products, therapies, or pharmaceutical claims.
  • No Regulatory Approval Claim: SciNarris is an educational resource, not a regulatory body, and does not issue formal preclearance or regulatory approvals.
  • No Affiliation Claim: SciNarris is not affiliated with, endorsed by, or acting on behalf of any regulatory agency (such as Health Canada or US FDA), pharmaceutical company, university, professional society, or preclearance body unless explicitly stated.
TRUST & TRANSPARENCY NAVIGATION

Explore Our Methodology & Policies

About SciNarris

Learn about SciNarris's mission, audience, and educational background.

Content Methodology

See our step-by-step approach to researching, referencing, and writing.

Updates & Corrections

Understand how we update content, correct errors, and handle reader feedback.